期刊名称：CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
AIMS AND SCOPE
Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, rheumatoid arthritis, HIV infection, and drug addiction. Scientific efforts in the above are of a multidisciplinary nature involving the physical, biological, medical, pharmaceutical, and engineering fields, and biomedical materials. With the vast increase in the numbers of papers and the tendency to fragmentize science, it becomes increasingly difficult to keep abreast of the literature, and even more difficult to sort out and to evaluate the importance and sometimes the reliability of the data, especially in cases where proprietary considerations are involved. Abstracts and non-critical articles often do not provide a sufficiently reliable basis for the proper assessment of a given field without the additional perusal of the original literature. The aim of Critical ReviewsTM in Therapeutic Drug Carrier Systems is to bridge this gap by publishing authoritative, objective, and comprehensive multidisciplinary critical review papers with emphasis on clinical applications. Both invited and contributed articles are considered for publication. The Journal will be of benefit to manufacturers, health-care providers, researchers, and patients, and will have wide appeal to clinicians, scientists, and engineers working in the field of drug carriers.
ISSN 0743-4863
Instructions to Authors
1. GENERAL INSTRUCTIONS. Manuscripts to be considered for publication
should be submitted in triplicate to Dr. Ajay K. Banga, Editor-in-
Chief,Mercer University, Department of Pharmaceutical Sciences, 3001 Mercer
University Drive, Atlanta GA 30341-4155, USA. banga_ak@mercer.edu.
2. SCOPE, OBJECTIVES, AND EDITORIAL POLICY. Therapeutic
uses of a variety of drug carrier systems have significant impact on the
treatment and potential cure of many chronic diseases, including cancer, diabetes
mellitus, rheumatoid arthritis,HIV infection, and drug addiction. Scientific
efforts in these areas are multidisciplinary, involving the physical, biological,
medical, pharmaceutical, biological materials, and engineering fields.
Articles concerning this field appear in a wide variety of journals.With
the vast increase in the number of articles and the tendency to fragment science,
it becomes increasingly difficult to keep abreast of the literature and to
sort out and evaluate the importance and reliability of the data, especially when
proprietary considerations are involved. Abstracts and noncritical articles often
do not provide a sufficiently reliable basis for proper assessment of a given
field without the additional perusal of the original literature. This journal
bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary
critical review papers with emphasis on clinical applications.
Both invited and contributed articles are subject to peer review.
3. PREPARATION OF MANUSCRIPTS.
a. Write in clear, concise English. If help with translation is desired, visit
www.begellhouse.com for the name and rates of the publisher’s recommended
agency in the US. The author is responsible for all aspects of
manuscript preparation. Extensive changes to the manuscript will not be
undertaken by the Editor.
b. Submit three (3) copies of the manuscript, which must be double spaced
and printed on US Letter or A4 paper. A diskette containing the text
file must accompany final (accepted and reviewed) manuscripts, along
with the revised and final hard copy.Acceptable formats for text files are
MicroSoft Word or WordPerfect. All pages should be numbered consecutively,
starting with the title page and ending with pages containing
references, tables, and figure legends, which should be grouped with furnished
art at the end of the manuscript to facilitate processing.
c. Authors should state in their manuscripts that any animals used in their
investigations have been cared for according to the Animal Rights Act and
the NIH Guide for Care and Use of Laboratory Animals.
d. A conflict-of-interest statement is required with each manuscript. This
statement will have no bearing on the editorial decision regarding publication
of the manuscript.Use one of the following statements: (1) “The
author or one or more of the authors has/have received or will receive
benefits from a commercial party related directly or indirectly to the subject
matter of this article.?(2) “No benefits have been or will be received
from a commercial party related directly or indirectly to the subject matter
of this article.?BR>e. All manuscripts must include the following:
Author information. Senior authors?full name, affiliation, and complete
mailing address; corresponding author’s email address, telephone number,
and fax number; affiliations for any additional authors.
Abstract/Key Words. All manuscripts should be accompanied by an abstract
not to exceed 200 words as well as a list of three to six key words (not used
in the title) to assist in cross-indexing your article.
Text. In addition to the main body of text, reviews should include an Introduction
or Historical Background, Summary/Conclusions, and, if applicable,
Acknowledgements. Number sections according to the following scheme:
I. PRINCIPAL HEADING
A. First Subheading
1. Second Subheading
a. Third Subheading
Italic or boldface type should be clearly indicated, and Greek or unusual characters
should be written plainly or explained by annotations.
4. REFERENCES. Literature references follow the Vancouver Style, available
in all commonly-used reference management programs and style manuala.
List names of all authors; “et al.?is not allowed.
References to the literature and all notes regardless of their nature should
be numbered consecutively, avoiding repitition by using the number that corresponds
to the original reference. Reference numbers should be typed as unparenthesized
superscripts following the author name(s), where appropriate,
or the sentence or clause containing the referenced material. Place numbers
after punctuation with no space between. Bibliographic references to classified
documents and reports or to unpublished material not generally available
to the scientific public should not be used.
Journal Articles
2. Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E.
Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br
J Cancer 1996; 73:1006-12.
Books
Personal author(s)
1. Ringsven MK, Bond D. Gerontology and leadership skills for nurses.
2 ed. Albany NY: Delmar, 1996.
Chapter in edited work
1. Phillips SJ,Whisnant JP.Hypertension and stroke. In:Laragh JH, Brenner
BM, editors.Hypertension: pathophysiology, diagnosis, and management.
2 ed. New York: Raven, 1995.
Editor(s), compiler(s) as author
1. Norman IJ, Redfern SJ, editors. Mental health care for elderly people.
New York: Churchill Livingstone, 1996.
Conference proceedings
1. Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology.
Proceedings of the 10th International Congress of EMG and
Clinical Neurophysiology; 95 Oct 15-19; Kyoto, Japan. Amsterdam:
Elsevier, 1996.
5. TABLES. Tables should be used only when they can present information
more effectively than can be done in running text. Avoid any arrangement
which unduly increases the depth of a table, and the column heads
should be made as brief as possible, using abbreviations liberally. Lines of data
should not be numbered nor run numbers given unless those numbers are
needed for reference in the text. Columns should not be used to contain only
one or two entries, nor should the same entry be repeated numerous times
consecutively.
6. ILLUSTRATIONS. Figures should be numbered in series and all
legends should be typed double spaced on a separate sheet. Both figures
and captions should be grouped at the end of the manuscript. Symbols (open
or closed circles, triangles, squares) and lettering should be sized for optimum
reproduction at a maximum width of 5" (8" for landscape). Color reproduction
of figures is possible at the author’s expense. Rates for color
printing will be furnished upon request. All illustrative material should be
mailed flat and protected by heavy cardboard, free of clips and staples.
?Line drawings and graphs. Original or computer-generated line drawings
and graphs should be submitted in black ink on separate sheets of
white opaque paper or as black and white glossy photographic prints.
Photocopies are unacceptable substitutes for original figures.
?Photographs. Photographs should be submitted as original, glossy
prints in color or grayscale. If cropping is necessary, please indicate on a
separate photocopy of the print so as not to damage the original.
Copyrighted Material. Authors who want to make use of artwork already
published, or verbatim quotations of text amounting to more than a few words,
are required by copyright law to ask the owner of the copyright (usually the
publisher) for permission. Assign proper credit in the caption (the copyright
holder may specify wording). Send copies of permissions clearly marked to
indicate the relevant figure or table. If authors use material from their own
published work, permission must be obtained from the publisher.
7. FORMUL?AND EQUATIONS. Empirical and structural formul?BR>and mathematical and chemical equations should be arranged to fill the
width of a single or double column. Subscripts and especially superscripts (i.e.
exponents) should be written with care.All signs such as +, ? =, <, or > should
be spaced, but the components of mathematical products should not be
spaced. Organic structural formul?should be submitted as copy suitable for
direct photographic reproduction. Do not use structures when a simple formula
will suffice. Do not use multiple lines unnecessarily; format simple fractional
expressions with a slant so they can be set on a single line. To avoid
errors, carefully arrange and execute all formula matter with special attention
to correctness of symbols, location of subscripts, superscripts, and electric
charges, and the placing and close join-up of single and multiple bond
lines. Use a copy of the structure in the text at the point of proper citation,
but when originals are provided, group these at the end of the manuscript.
All furnished art must be complete.
8. COPYRIGHT RELEASE AND OFFPRINTS. Forms and instructions
for release of copyright and for ordering offprints, copies of issues, and
subscriptions will be included with the page proofs sent to authors.
Editorial Board
Srini Tenjarla, Ph.D.
Associate Director. Shire Pharmaceutical Development 1901 Research Boulevard, Suite 500 Rockville, MD 20850
Ajay K. Banga, Ph.D.
Associate Professor, Pharmaceutical Sciences, Mercer University, 3001 Mercer University Drive Atlanta GA 30341-4155
S. S. Davis, Ph.D., D.Sc.
Department of Pharmaceutical Sciences School of Pharmacy Nottingham University University Park, Nottingham NG7 2RD
Mitsuru Hashida, Ph.D.
Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
Anthony J. Hickey, Ph.D.
School of Pharmacy The University of North Carolina Chapel Hill, NC 27599-7360
Jeffrey Hughes, Ph.D.
Department of Pharmaceutics College of Pharmacy University of Florida GainesviUe, FL 32610-0494
Jindrich Kopecek, Ph.D.
Department of Bioengineering University of Utah Salt Lake City, UT 84112
Lee D. Leserman, M.D., Ph.D.
Centre lmmunologie de Marseilles-Luminy F-13288 Marseilles, Cedex2, France
Derek OHagan, Ph.D.
Chiron Corporation 4560 Horton Street Emeryville, CA 94608-2916
Joseph Robinson, Ph.D.
School of Pharmacy University of Wisconsin Madison, WI 53706
Abraham Rubinstein, Ph.D.
School of Pharmacy, Faculty of Medicine The Adolph Weinberger Building The Hebrew University, P.O. Box 12065 Jerusalem 91120, Israel
Janos Szebeni, M.D., Ph.D.
Department of Membrane Biochemistry Walter Reed Army Institute of Research 503 Robert Grant Avenue Silver Spring, MD 20910-7580
Su Il Yum, Ph.D.
DURECT Corporation 10240 Bubb Road Cupertino CA 95014-4166
|
